BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- Sponsors Allergan
- 11 Jul 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 The trial was completed in Czech Republic (end date: 07-03-2016).
- 08 Jun 2016 This trial was completed in Denmark (end date: 07-03-2016), according to European Clinical Trials Database